StockData
Merck & Co., Inc. logo

Merck & Co., Inc.

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30250% above fair value
$149.52+3.19 (+2.18%)

Close on Oct 30, 2026Market cap $368.89BP/E 119.6Yield 2.19%

Merck Other (Income) Expense Breakdown by Year

Other (Income) Expense Breakdown — Net Periodic Defined Benefit Plan (Credit) Cost ($M) ($M)

Merck Other (Income) Expense Breakdown: -$615M in FY2025, down 2.8% from a year earlier.

Latest, FY2025
-615
Period ended Dec 31, 2025
Change on a year earlier
-2.8%
-633 in FY2024
History
7 years
Since FY2017
Sources
5
Documents cited below

Where the FY2025 figure comes from

“|| Net periodic defined benefit plan (credit) cost other than service cost | (163 | ) | (157 | ) | (615 | ) | (633 | )”

Source: Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗

Reported in Form 8-K Table 4.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOther (Income) Expense Breakdown — Net Periodic Defined Benefit Plan (Credit) Cost ($M) ($M)Year on yearSource
FY2025Dec 31, 2025-615-2.8%Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗
FY2024Dec 31, 2024-633+27.1%Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗
FY2023Dec 31, 2023-498+78.5%Form 8-K (tm255059d1_ex99-1.htm, filed 2025-02-04) ↗
FY2022Dec 31, 2022-279–Form 8-K (tm244517d1_ex99-1.htm, filed 2024-02-01) ↗
FY2019Dec 31, 2019-545+6.4%Form 8-K (tm206551d1_ex99-1.htm, filed 2020-02-05) ↗
FY2018Dec 31, 2018-5120.0%Form 8-K (tm206551d1_ex99-1.htm, filed 2020-02-05) ↗
FY2017Dec 31, 2017-512–Form 8-K (a19-3795_1ex99d1.htm, filed 2019-02-01) ↗

Cite this data

StockData. (2026). Merck Other (Income) Expense Breakdown ($M), annual FY2017–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/other-inc-exp-db-credit

See every metric in the Merck KPI table. Data updated Oct 26, 2026.